James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
James Knowles, Vice President, Global Regulatory Policy and Scientific Affairs at Plasma Protein Therapeutics Association, shared a post on LinkedIn:
”Big thanks for Walter Kelley and others at Takeda PDT business unit and BioLife Plasma Services invitation to attend the Takeda facility tour at their test lab and manufacturing plant just outside Atlanta, GA. I will never turn down an opportunity to go back inside these unique manufacturing facilities throughout the world to be refreshed on the complex and highly regulated process to guarantee safety during the production of the medicines for our patients.
Really enjoyed the presentation by Marla C. Troughton about our industry, highlighting differences and similarities between the transfusion and plasma world and thank you for the many times you included Plasma Protein Therapeutics Association (PPTA) in your talk and I was happy to interject. It highlights the strong relationship between our industry association and company members.
And speaking of associations, now it’s time to turn my attention to the 2026 AABB meeting, here in Atlanta, where I will be attending several AABB committee meetings that I am part of and presenting to the attendees in a joint session with AABB staff that will highlight how blood banks can get involved in the supply of recovered plasma, and explaining what the PDT industry does with that plasma, including the medicines made and patient groups we serve.”

Stay updated with Hemostasis Today.
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial
-
Oct 20, 2026, 03:37Rucha Patil: Scaling POC Diagnostics for Haemophilia A and VWD Across India
-
Oct 20, 2026, 03:31Zena Vexler: Targeting Neutrophil Elastase and NETosis to Mitigate Infection-Triggered Childhood Stroke
-
Oct 20, 2026, 03:24Chaza Alaji: Diagnosing Protein C and Protein S Deficiency